Stock Alert: Tortoise Acquisition Hits New 52-week High On Merger With Volta Industries

By RTTNews Staff Writer   ✉   | Published:

Shares of Tortoise Acquisition Corp. II (SNPR), a special purpose acquisition company, are gaining more than 34 percent or $4.46 in Monday's morning trade at $17.36, after surging to a new 52-week high of $18.33.

Volta Industries Inc., an operator of public electric vehicle charging infrastructure, and Tortoise Acquisition said Monday they intend to merge. Upon the closing of the transaction, the combined entity will be named Volta Inc. and remain listed on the New York Stock Exchange or NYSE under the new ticker symbol "VLTA."

The companies expect the pro forma equity value of the combined company to exceed $2 billion at the $10.00 per share PIPE price and assuming minimal redemptions by Tortoise Acquisition public shareholders. The transaction is expected to close late in the second quarter of 2021.

Tortoise Acquisition has traded in a range of $9.46 to $18.33 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon warehouse workers in Alabama are starting their mail-in voting on unionization Monday after the National Labor Relations Board or NLRB rejected the company's request for a delay in election. The regulator will mail ballots to around 6,000 workers at the warehouse starting Monday to decide whether to unionize, and the ballots must be returned by March 29. The U.S. Food and Drug Administration approved a new treatment for adult patients with certain types of large B-cell lymphoma (LBCL) who have not responded to, or who have relapsed after, at least two other types of systemic treatment. Bristol-Myers Squibb's Breyanzi (lisocabtagene maraleucel) is the third gene therapy to be approved by the FDA for Large-B-Cell Lymphoma. South Africa has halted the rollout of AstraZeneca- Oxford vaccine against Covid-19 after a study showed the vaccine provided minimal protection against a new variant. South African Health Minister Zweli Mkhize, while speaking at a news conference on Sunday, said there is a temporary hold as the government waits for further advice on how to proceed with the AstraZeneca- Oxford vaccine...